Six months ago, I wrote about pharmaceutical companies’ use of twitter. At the time, only 4 big pharmacos were experimenting with this new communication channel.
Over these past months, I have seen these companies (and others that followed since) gather insight and savvy into their use of twitter. It is thus time to look beyond the mere fact that pharmacos ARE using twitter and to analyze the finer details of HOW they are using it.
My next 3-4 blog posts will therefore be dedicated to the “pharma twittersphere“. In particular, I will be looking at:
1. who pharmacos reach with twitter and the differences between companies
2. how they participate (or not) in the twitter conversation
3. how they could take twitter to the next level in terms of topics and collaboration.
I therefore will start of my “state of the pharma twittersphere” by asking for your help. Please answer the following three questions as an input to my analysis:
I look forward to your thoughts and input. As always, feel free to also use the comment section to elaborate on your thoughts